13F Pro Quality Score

51.4/100

Rank #1,399 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

70.9/100

Profitability

27.0/100

Balance Sheet

30.9/100

Earnings Quality

30.0/100

Free Cash Flow

71.6/100

Institutional Flow

74.7/100

Revenue Scale

62.9/100

Dilution Risk

36.1/100

RDNT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for RadNet, Inc. (RDNT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RDNT at 51.4/100 on a 32-signal composite quality model, placing it at rank #1,399 of 2,879 stocks — the top half of the AI-ranked universe. Areas of concern include profitability (27.0) and earnings quality (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 36.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), RadNet, Inc. reports quarterly revenue of $575.6M, net income of $-33.5M, free cash flow of $79.0M. Top institutional holders of RDNT by reported 13-F value include BlackRock,, RTW INVESTMENTS,, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. RDNT trades on the Nasdaq exchange and files with the SEC under CIK 790526. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RDNT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RadNet, Inc. directly from SEC EDGAR. RadNet, Inc.'s 13F Pro composite quality score has ranged between 8 and 70 since 2021, currently 51.4 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about RadNet, Inc.

Quirks, history, and lore behind RDNT — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. healthcare services company · mid-cap · listed on Nasdaq · headquartered in Los Angeles, California.
  • 2
    The Numbers
    Operates over 400 outpatient imaging centers across the U.S., making it one of the largest networks of its kind in the country.
  • 3
    The History
    Founded in 1981, it spent decades quietly buying up independent imaging clinics, turning a fragmented mom-and-pop industry into a scaled national platform.
  • 4
    The Secret
    It's betting big on AI-powered diagnostics to read scans faster and catch what human eyes miss — quietly becoming a tech-forward healthcare company in a lab coat.
  • 5
    The Lore
    Its home turf of Southern California remains its largest market, and it has expanded into New York, New Jersey, and Maryland — basically wherever bodies need scanning.
  • 6
    The Giveaway
    If you've ever had an MRI, CT scan, or X-ray at a standalone imaging center in a U.S. strip mall, there's a decent chance the sign outside said RadNet.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$575.6M

Net Income

Q1 2026

$-33.5M

Free Cash Flow

Q1 2026

$79.0M

ROIC

Q1 2026

-1.1%

D/E Ratio

Q1 2026

1.03

Get alerted when RDNT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for RadNet, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of RDNT

Put RDNT on your watchlist

Track score changes the day RadNet, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is RDNT a good stock to buy?

13F Pro's AI-powered analysis of RadNet, Inc. (RDNT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for RDNT are available on the RDNT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own RDNT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling RDNT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of RadNet, Inc.'s investment landscape.